Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Passage Bio Inc/
Recent news which mentions Passage Bio Inc/
Lab Notes: Wedgewood Pharmacy acquires Colorado lab; Aprea Therapeutics raises $5.5M
March 03, 2023
Tickers
INNO
Tags
William Chou
Ocugen Inc/
Health Care
From
Business Journals
Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy
December 23, 2022
Tickers
INNO
Tags
Niranjan Y/ Sardesai
Zynerba Pharmaceuticals Inc/
Timothy Henkel
From
Business Journals
Lab notes: Adaptimmune to reduce workforce; NRx completes $11M debt financing
November 11, 2022
Tickers
INNO
Tags
Nabriva Therapeutics plc Ireland
Incyte Corp/
Lannett Co Inc
From
Business Journals
Lab Notes: Adaptimmune to expand manufacturing at Navy Yard; Helius raises $18M with stock sale
August 12, 2022
Tickers
INNO
Tags
Helius Medical Technologies Inc/ (DE)
Passage Bio Inc/
Nabriva Therapeutics plc Ireland
From
Business Journals
Lab Notes: Mark Cuban increases investment in Strella Biotech as part of multimillion-dollar VC round
June 10, 2022
Tickers
INNO
Tags
Pharmaceuticals
Immunome Inc/
Marinus Pharmaceuticals
From
Business Journals
Passage Bio trims workforce by 13%, narrows R&D focus to extend cash runway
March 15, 2022
Tags
Insurance
Pharmaceuticals
Mark Forman
From
Business Journals
Lab Notes: Optinose advances sinusitis drug-device combo; WuXi launches new technology
March 11, 2022
Tickers
INNO
Tags
OptiNose Inc/
Passage Bio Inc/
Strados Labs/ Inc
From
Business Journals
Passage Bio further expands gene therapy research partnership with Penn
December 08, 2021
Tags
Pharmaceuticals
Insurance
Passage Bio Inc/
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.